Switzerland· 68587003

Zafrilla 2 mg, Tabletten

A dienogest product containing dienogestum, registered in Switzerland by Gedeon Richter (Schweiz) AG and dispensed under Swissmedic category B. The same ATC class is registered in 16 of our 19 countries.

Cat B (Swissmedic)ATC G03DB08

Checked against Swissmedic (Switzerland) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about dienogestumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Dienogest is registered in 16 of 19 countries.

Countries holding a registration under ATC G03DB08 (dienogest), each read from that country’s own register.

This record: Switzerland, from Swissmedic (Switzerland)
9 of them publish a price we can compare per daily dose

Search dienogest products by name

Dienogest · ATC G03DB08

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dienogest costs, country by country.

Normalised to the WHO defined daily dose (2 mg), the median price runs from $0.48 in France to $3.02 in Switzerland — a ×6.3 gap.

Switzerland: $3.02 per daily dose (median across products in the class)
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Dienogest · price per daily dose (2 mg)

USD · FX 28 Sept 2026

CH Switzerland$3.02
IT Italy$0.69
FR France$0.48

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)

Active substance: dienogestum
Manufacturer: Gedeon Richter (Schweiz) AG
Country: Switzerland (CH)
ATC code: G03DB08
ATC class: Dienogest
Defined daily dose: 2 mg, O
Swissmedic category: B
Reimbursed: No
Source register: Swissmedic (Switzerland)
Last checked: September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

54 interactions on record for dienogest.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check dienogest against other medicines How interaction checks work

Dienogest · interactions on record

54 records

12 severe
38 moderate
4 minor

Most severe, free to view

GriseofulvinD01AA08severe
GriseofulvinD01BA01severe
DabrafenibL01EC02severe
EncorafenibL01EC03severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dienogest in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dienogest products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Aridya, Diemono
Belgium · Dimetrum, Pauline
Bulgaria · Зафрила
Cyprus · Dienogest
Czechia · Aridya, Endovelle
Germany · Diemono, Dienogest Aristo
Denmark · Dienogest Besins, Dienosis
Estonia · Visannette
Spain · Adienocare, Dienogest Adalvo
Finland · Dienogest, Dienogest Besins
France · Dienogest Bailleul, Dienogest Laboratoires Majorelle
United Kingdom (Northern Ireland) · Dienogest, Dienogest Exeltis Healthcare
Greece · Efilda
Croatia · Visanne, Zafrilla
Hungary · Tubanis, Visanne
Ireland · Dienogest Stragen, Zafrilla
Iceland · Dienogest Besins, Visanne
Italy · Devicius®, Dienogest Adalvo
Lithuania · Sawis, Visannette
Luxembourg · Dimetrum, Pauline
Latvia · Visannette
Malta · Zafrilla
Netherlands · Dienogest Bailleul, Dienogest Stragen
Norway · Dienogest Besins, Visanne
Poland · Aridya, Diemono
Portugal · Endovelle, Metrius
Romania · Visanne, Zafrilla
Sweden · Dienogest, Dienogest León Farma
Slovenia · Dienogest Gedeon Richter, Visanne
Slovakia · Endovelle, Visanne

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c54fe2f1-bb2c-4ecf-8f5b-0b9f66dbd20a
GET /v1/drugs/c54fe2f1-bb2c-4ecf-8f5b-0b9f66dbd20a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}

API reference MCP server Plans

See everything about dienogest.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console